Identifying biomarkers that can be used as diagnostics or predictors of treatment response
(theranostics) in people with schizophrenia (Sz) will be an important step towards being able …

Oxidative stress is a well-recognized participant in the pathophysiology of multiple brain
disorders, particularly neurodegenerative conditions such as Alzheimer's and Parkinson's …

Treatment and prevention strategies for schizophrenia require knowledge about the
mechanisms involved in the psychotic transition. Increasing evidence suggests a redox …

Objectives: Major depressive disorder is diagnosed on the basis of patient's self-reported
experiences, behavior reported by relatives, and a mental status examination, and yet we do …

In vivo measurement of neurotransmitters and modulators is now feasible with advanced
proton magnetic resonance spectroscopy (1 H MRS) techniques. This review provides a …

Objective To investigate possible differences in peripheral levels of chemokines, BDNF and
oxidative markers between patients with Schizophrenia (SZ) and matched healthy controls …

Major depression is a most frequent disorder, its diagnosis depends on patient interview,
and yet we do not have a reliable biomarker for depression. Oxidative stress is defined as …

Significance: NOX2 is important for host defense, and yet is implicated in a large number of
diseases in which inflammation plays a role in pathogenesis. These include acute and …

Supplementation with omega-3 has been identified as an adjunctive alternative for the
treatment of psychiatric disorders, in order to minimize symptoms. Considering the lack of …

Involvement of oxidative stress in the pathophysiology of schizophrenia (SZ) is suggested by
studies of peripheral tissue. Nonetheless, it is unclear how such biological changes are …